(Q34549762)

English

Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

mental health care

1 reference

based on heuristic

inferred from title

object named as

Gayan Perera

1

0 references

Mizanur Khondoker

object named as

Mizanur Khondoker

2

0 references

object named as

Gerome Breen

4

0 references

object named as

Robert Stewart

5

0 references

Matthew Broadbent

3

object named as

Matthew Broadbent

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

20 November 2014

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

9

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

e109484

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

20 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Prevalence of dementia in African-Caribbean compared with UK-born White older people: two-stage cross-sectional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Pharmacotherapy and prevention of vascular dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Donepezil for dementia due to Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Do atypical antipsychotics cause stroke?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Factors affecting the age of onset and rate of progression of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Alzheimer's disease: a correlative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

“Mini-mental state”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

7 July 2018

Investigation of responders and non-responders to long-term donepezil treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109484

21 January 2018

Misuse of the linear mixed model when evaluating risk factors of cognitive decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

27 October 2018

Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239015

27 October 2018

Identifiers

10.1371/JOURNAL.PONE.0109484

1 reference

Europe PubMed Central

3 August 2017

2014PLoSO...9j9484P

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34549762&oldid=1859632111"